Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)
- 13 July 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 39 (15) , 5657-5667
Abstract
Non-structural protein 1 (nsp1) is found in all Betacoronavirus genus, an important viral group that causes severe respiratory human diseases. This protein has significant role in pathogenesis and it is considered a probably major virulence factor. As it is absent in humans, it becomes an interesting target of study, especially when it comes to the rational search for drugs, since it increases the specificity of the target and reduces possible adverse effects that may be caused to the patient. Using approaches in silico we seek to study the behavior of nsp1 in solution to obtain its most stable conformation and find possible drugs with affinity to all of them. For this purpose, complete model of nsp1 of SARS-CoV-2 were predicted and its stability analyzed by molecular dynamics simulations in five different replicas. After main pocket validation using two control drugs and the main conformations of nsp1, molecular docking based on virtual screening were performed to identify novel potential inhibitors from DrugBank database. It has been found 16 molecules in common to all five nsp1 replica conformations. Three of them was ranked as the best compounds among them and showed better energy score than control molecules that have in vitro activity against nsp1 from SARS-CoV-2. The results pointed out here suggest new potential drugs for therapy to aid the rational drug search against COVID-19. Communicated by Ramaswamy H. SarmaKeywords
This publication has 42 references indexed in Scilit:
- Insights from molecular dynamics simulations for computational protein designMolecular Systems Design & Engineering, 2017
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including AlisporivirVirus Research, 2014
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual ChallengeAnnals of Saudi Medicine, 2013
- The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”Journal of the Formosan Medical Association, 2013
- Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?Journal of Infection, 2012
- H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulationsNucleic Acids Research, 2012
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- ChemmineR: a compound mining framework for RBioinformatics, 2008
- Novel β-Barrel Fold in the Nuclear Magnetic Resonance Structure of the Replicase Nonstructural Protein 1 from the Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2007